SEC Form 4 · accession 0001209191-16-153753
GENOMIC HEALTH INC · GHDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kimberly J Popovits
Officer — President and CEO · Director
Period of report
Dec 5, 2016
Accepted (ET)
Dec 6, 2016 · 7:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001131324
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 5, 2016 | M | 5,000 | $23.31 | A | 64,620 | D | |
| Common StockF1,F2,F3 | Dec 5, 2016 | S | 5,000 | $30.02 | D | 59,620 | D | |
| Common Stock | holding | — | — | — | 12,298 | I | Held by UBS for Benefit of Kimberly Popovits | |
| Common Stock | holding | — | — | — | 16,825 | I | Held in trust for the benefit of Ms. Popovits' son, of which Ms. Popovits is trustee. | |
| Common Stock | holding | — | — | — | 200,851 | I | Held by the Popovits 2010 Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F4 | $23.31 | Dec 5, 2016 | M | 5,000 | D | — | Dec 6, 2017 | Common Stock | 0 | 7,900 | D |
Explanation of responses
- F1These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on June 6, 2016.
- F2Represents actual sale price.
- F3Includes an aggregate of 30,634 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
- F4The option became exercisable as to 25% of the shares on December 6, 2008, and became exercisable as to 1/48th of the shares each full month thereafter.